Meiji Yasuda Life Insurance’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-2,912
| Closed | -$327K | – | 325 |
|
2020
Q2 | $327K | Hold |
2,912
| – | – | 0.01% | 252 |
|
2020
Q1 | $261K | Buy |
2,912
+227
| +8% | +$20.3K | 0.05% | 237 |
|
2019
Q4 | $290K | Hold |
2,685
| – | – | 0.04% | 279 |
|
2019
Q3 | $263K | Sell |
2,685
-314
| -10% | -$30.8K | 0.04% | 286 |
|
2019
Q2 | $393K | Sell |
2,999
-5,066
| -63% | -$664K | 0.06% | 259 |
|
2019
Q1 | $1.09M | Sell |
8,065
-455
| -5% | -$61.5K | 0.16% | 152 |
|
2018
Q4 | $830K | Buy |
8,520
+4,220
| +98% | +$411K | 0.13% | 177 |
|
2018
Q3 | $598K | Hold |
4,300
| – | – | 0.07% | 232 |
|
2018
Q2 | $534K | Sell |
4,300
-1,690
| -28% | -$210K | 0.07% | 230 |
|
2018
Q1 | $668K | Sell |
5,990
-310
| -5% | -$34.6K | 0.1% | 197 |
|
2017
Q4 | $753K | Buy |
6,300
+2,000
| +47% | +$239K | 0.1% | 191 |
|
2017
Q3 | $603K | Buy |
+4,300
| New | +$603K | 0.09% | 197 |
|
2016
Q4 | – | Sell |
-4,597
| Closed | -$563K | – | 364 |
|
2016
Q3 | $563K | Hold |
4,597
| – | – | 0.08% | 228 |
|
2016
Q2 | $537K | Hold |
4,597
| – | – | 0.09% | 193 |
|
2016
Q1 | $640K | Hold |
4,597
| – | – | 0.1% | 185 |
|
2015
Q4 | $877K | Sell |
4,597
-260
| -5% | -$49.6K | 0.14% | 161 |
|
2015
Q3 | $760K | Sell |
4,857
-1,430
| -23% | -$224K | 0.13% | 171 |
|
2015
Q2 | $1.14M | Sell |
6,287
-700
| -10% | -$127K | 0.18% | 152 |
|
2015
Q1 | $1.21M | Sell |
6,987
-1,488
| -18% | -$258K | 0.19% | 153 |
|
2014
Q4 | $1.57M | Buy |
8,475
+90
| +1% | +$16.7K | 0.23% | 108 |
|
2014
Q3 | $1.39M | Buy |
8,385
+1,743
| +26% | +$289K | 0.21% | 113 |
|
2014
Q2 | $1.04M | Sell |
6,642
-600
| -8% | -$93.8K | 0.16% | 142 |
|
2014
Q1 | $1.1M | Sell |
7,242
-823
| -10% | -$125K | 0.19% | 132 |
|
2013
Q4 | $1.07M | Hold |
8,065
| – | – | 0.18% | 132 |
|
2013
Q3 | $937K | Sell |
8,065
-785
| -9% | -$91.2K | 0.17% | 146 |
|
2013
Q2 | $816K | Buy |
+8,850
| New | +$816K | 0.15% | 157 |
|